CLINICAL_TRIALS
trial_result
· 2011-04-05
Clinical Trial Update: Dasatinib in Imatinib Resistant/Intolerant Chinese CML (Chronic and Advanced Phase) Subjects [Phase 2]
Summary
Phase 2 trial update evaluating dasatinib in imatinib-resistant or intolerant Chinese chronic myeloid leukemia patients, completed with results posted in 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2011-04-05